Donald McDonnell, PhD, is the Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology, as well as professor of medicine; pharmacology and cancer biology; and cell biology at the Duke University School of Medicine. He is also a member of the Duke Cancer Institute.